|
CDRH to Strengthen Postmarket Surveillance, Plans Proactive Electronic Data Analysis
Building on the enhanced tracking abilities that will be created by implementation of unique device identifiers (UDI), the FDA plans to begin rolling out by year’s end an enhanced postmarket surveillance program for medical devices.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives